Encore une fois? French uncovers yet more regulatory misdeeds
This article was originally published in Clinica
Executive Summary
Over a year after the PIP breast implant debacle hit the global media headlines, France is once more under the spotlight as another homegrown medtech company – this time, a hip implant maker called Ceraver – has fallen foul of healthcare product regulations.